FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $29.1 million versus the consensus estimate of $31.46 million.
I am very proud of the way that the entire Catalyst team has quickly responded and... More

